Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$350.25 - $422.63 $1.15 Million - $1.39 Million
-3,286 Reduced 4.86%
64,289 $23 Million
Q2 2023

Aug 14, 2023

SELL
$359.49 - $486.4 $4.85 Million - $6.57 Million
-13,498 Reduced 16.65%
67,575 $25.6 Million
Q1 2023

May 12, 2023

BUY
$418.69 - $503.0 $858,733 - $1.03 Million
2,051 Added 2.6%
81,073 $38.8 Million
Q4 2022

Feb 13, 2023

BUY
$351.71 - $456.01 $7.03 Million - $9.12 Million
19,996 Added 33.88%
79,022 $33.2 Million
Q3 2022

Nov 14, 2022

BUY
$412.59 - $563.26 $5.64 Million - $7.7 Million
13,677 Added 30.16%
59,026 $24.6 Million
Q2 2022

Aug 12, 2022

BUY
$463.67 - $597.16 $7.81 Million - $10.1 Million
16,838 Added 59.06%
45,349 $22.4 Million
Q1 2022

May 16, 2022

SELL
$524.57 - $735.42 $463,719 - $650,111
-884 Reduced 3.01%
28,511 $16.1 Million
Q4 2021

Feb 14, 2022

SELL
$708.84 - $794.68 $389,862 - $437,074
-550 Reduced 1.84%
29,395 $22.2 Million
Q3 2021

Nov 15, 2021

SELL
$657.71 - $825.77 $426,853 - $535,924
-649 Reduced 2.12%
29,945 $22.3 Million
Q2 2021

Aug 16, 2021

SELL
$576.64 - $649.04 $1.16 Million - $1.31 Million
-2,013 Reduced 6.17%
30,594 $19.7 Million
Q1 2021

May 17, 2021

SELL
$547.01 - $662.35 $10 Million - $12.1 Million
-18,282 Reduced 35.93%
32,607 $18.6 Million
Q4 2020

Feb 16, 2021

SELL
$510.68 - $643.45 $12 Million - $15.1 Million
-23,492 Reduced 31.58%
50,889 $29.7 Million
Q3 2020

Nov 13, 2020

SELL
$454.43 - $535.6 $4.38 Million - $5.17 Million
-9,644 Reduced 11.48%
74,381 $38.3 Million
Q2 2020

Aug 14, 2020

SELL
$334.87 - $493.06 $21.2 Million - $31.2 Million
-63,320 Reduced 42.97%
84,025 $37.9 Million
Q1 2020

May 15, 2020

SELL
$320.01 - $409.07 $2.15 Million - $2.75 Million
-6,733 Reduced 4.37%
147,345 $51.7 Million
Q4 2019

Feb 13, 2020

SELL
$319.73 - $374.2 $4.38 Million - $5.13 Million
-13,707 Reduced 8.17%
154,078 $57 Million
Q3 2019

Nov 13, 2019

SELL
$304.55 - $345.24 $1.89 Million - $2.15 Million
-6,220 Reduced 3.57%
167,785 $55.8 Million
Q2 2019

Aug 13, 2019

SELL
$286.93 - $312.59 $1.55 Million - $1.68 Million
-5,385 Reduced 3.0%
174,005 $54.4 Million
Q1 2019

May 14, 2019

SELL
$224.3 - $317.41 $4.77 Million - $6.75 Million
-21,266 Reduced 10.6%
179,390 $54.8 Million
Q4 2018

Feb 13, 2019

BUY
$220.1 - $309.0 $3.04 Million - $4.26 Million
13,798 Added 7.38%
200,656 $46.6 Million
Q3 2018

Nov 14, 2018

SELL
$289.28 - $326.15 $1.17 Million - $1.32 Million
-4,054 Reduced 2.12%
186,858 $58.5 Million
Q2 2018

Aug 14, 2018

BUY
$244.1 - $303.88 $9.53 Million - $11.9 Million
39,046 Added 25.71%
190,912 $55.1 Million
Q1 2018

May 15, 2018

BUY
$233.97 - $274.11 $10.6 Million - $12.5 Million
45,446 Added 42.7%
151,866 $38 Million
Q4 2017

Feb 14, 2018

SELL
$216.94 - $271.3 $37.1 Million - $46.4 Million
-170,874 Reduced 61.62%
106,420 $25.4 Million
Q3 2017

Nov 14, 2017

SELL
$212.27 - $242.28 $730,208 - $833,443
-3,440 Reduced 1.23%
277,294 $61.6 Million
Q3 2017

Nov 13, 2017

SELL
$212.27 - $242.28 $8.11 Million - $9.26 Million
-38,208 Reduced 11.98%
280,734 $62.4 Million
Q2 2017

Aug 14, 2017

BUY
N/A
318,942
318,942 $72.2 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.1B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Cramer Rosenthal Mcglynn LLC Portfolio

Follow Cramer Rosenthal Mcglynn LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cramer Rosenthal Mcglynn LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cramer Rosenthal Mcglynn LLC with notifications on news.